Validation of the Swedish Multiple Sclerosis Register Further Improving a Resource for Pharmacoepidemiologic EvaluationsShow others and affiliations
2019 (English)In: Epidemiology, ISSN 1044-3983, E-ISSN 1531-5487, Vol. 30, no 2, p. 230-233Article in journal (Refereed) Published
Abstract [en]
The Swedish Multiple Sclerosis Register is a national register monitoring treatment and clinical course for all Swedish multiple sclerosis (MS) patients, with high coverage and close integration with the clinic. Despite its great value for epidemiologic research, it has not previously been validated. In this brief report, we summarize a large validation of amp;gt;3,000 patients in the register using clinical chart review in the context of the COMBAT-MS study. While further improving the data quality for a central cohort of patients available for future epidemiologic research, this study also allowed us to estimate the accuracy and completeness of the register data.
Place, publisher, year, edition, pages
LIPPINCOTT WILLIAMS & WILKINS , 2019. Vol. 30, no 2, p. 230-233
Keywords [en]
Multiple sclerosis; Pharmacoepidemiology; Register; Validation
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
URN: urn:nbn:se:liu:diva-154830DOI: 10.1097/EDE.0000000000000948ISI: 000458417200017PubMedID: 30721167OAI: oai:DiVA.org:liu-154830DiVA, id: diva2:1293670
Note
Funding Agencies|Patient-Centered Outcomes Research Institute (PCORI) Award [MS-1511-33196]; Swedish Foundation for MS Research; Biogen; Roche; Biogen Idec; Genzyme; Novartis
2019-03-052019-03-052019-03-05